Aims: The odor identification ability and its hedonic judgment in patients with schizophrenia were evaluated in the study. The association between olfactory performance and negative symptoms and β-endorphin concentration was also analyzed.
| INTRODUC TI ON
Some brain regions crucial for schizophrenia such as amygdala, hippocampus, and prefrontal cortex have connections with olfactory system. These structures also take part in hedonic processing of external stimuli. 1 In healthy humans, the prefrontal cortex is involved in such olfactory functions as odor identification, odor discrimination, judgment of the hedonic value of odors, and odor memory. 2 Therefore, this structure may play a key role in dysfunctions believed to manifest as direct connections between the olfactory bulb and the prefrontal cortex. 3, 4 These findings indicate that olfactory processing engages a complex and distributed network of brain regions, whose pattern of activation varies depending on the specific requirements of the task. Some authors suggest that both olfactory deficits and negative symptoms, such as anhedonia and social impairments, may reflect dysfunctions of the circuitry mediated by the prefrontal cortex. 5 Various olfactory dysfunctions such as deficits in olfactory discrimination and similarity judgment, detection threshold sensitivity, and recognition memory have been widely reported in patients with schizophrenia. Nevertheless, the majority of reports refer to odor identification impairment. 6 A close connection exists between odors and emotions.
In a physiological manner, odor stimuli are processed according to their emotional content, and no emotional context is required for their processing. Similar to emotions, odors may be given positive, negative, or neutral valence. 1 There is no relationship between olfactory deficits in schizophrenia and smoking cigarettes, 7, 8 medication status, or illness duration, 9 even if these factors partly contribute to this phenomenon in some patients. Therefore, although olfactory disturbances are often described in schizophrenia, much less is known about hedonic processing than olfaction in subjects with this condition. Several reports have noted attenuated pleasantness ratings for pleasant odors in patients, but not for unpleasant odors, 10, 11 while others have reported increased pleasantness ratings in patients. 2, 12 Crespo-Facorro et al 13 in positron emission tomography (PET) found that patients with schizophrenia rated pleasant odors as being significantly more neutral than in controls and that these deficits in valence judgment were associated with prefrontal cortex and limbic system activation impairment. Preliminary conclusions of studies in this field indicated that patients with schizophrenia perceive odor valence incorrect. These abnormalities are associated with negative symptoms. Thus, limbic system may underlie olfactory hedonic dysfunction.
Some evidence suggests that olfactory function is affected by opioids. Three known opioid receptor types, that is, δ, μ, and κ, are present in the olfactory system of several species. 14 The olfactory bulb contains the highest density of δ receptors. Moreover, μ receptors are mainly localized in this brain region. 15 In experimental conditions, it was found that morphine modifies the development of odor performance in rats.
Lötsch et al 14 reported that administration of the opioid remifentanil causes increase in subjective olfactory thresholds in healthy human volunteers. Meanwhile, it has little or no influence on odor discrimination or odor identification performance. The endogenous opioid system is involved in the evaluation of consummatory value and relative preference of food, 16 whereas the dopaminergic system is important in volitional food reward contingencies. 17 Beta-endorphin (BE) is one of endogenous opioid peptide. It has not only strong analgesic properties but also several other biological functions. 18 Endogenous opioids may be downstream products of the dopaminergic system and neuromodulators of reward and motivation circuitries. They have been implicated in the evaluation of the hedonic, pleasant properties that make a reward desired and wanted. 19 Endogenous opioid system disturbances have been observed in schizophrenia. The excess of endorphins in schizophrenia is one of the postulated hypothesis. 20 In our previous study, we also found about 20% higher BE concentration in patients with schizophrenia than in healthy controls. 21 The presented study investigated the relationship between odor valences on odor identification deficits in patients with schizophrenia and assessed their subjective hedonic judgment of odors.
Available scientific data suggest that BE is involved in pathogenesis of schizophrenia, yet this biological mechanism is still unclear. The goal of this study was to investigate whether BE concentration is related with olfactory performance and psychopathological symptoms profile in schizophrenia. To our knowledge, this is the first study which considers the impact of BE on olfactory function in schizophrenia.
| ME THODS

| Participants
The forty-eight patients with schizophrenia diagnosed according to the ICD-10 criteria were recruited to the study, along with 21 healthy individuals. The patients were clinically evaluated by a senior psychiatrist. The Positive and Negative Syndrome Scale (PANSS) was administered, and they were classified into negative (PN, n = 23) and non-negative (PP, n = 25) psychopathological subtypes using the PANSS composite index. 22 The composite index is obtained by subtracting the PANSS negative symptoms subscale score from the positive subscale score. The difference score (ranges from −42 to +42)
reflecting the degree of predominance of one positive or negative syndrome in relation to the other. The classification into the psychopathological subtypes was carried out using the original PANSS validation data. The 3 study groups did not differ with regard to age (P = . 25) and sex composition (χ 2 = 0.09; P = .95) ( Table 1 ). All patients were undergoing first-generation or second-generation antipsychotic in thera- 
| Biochemical assay
The BE assay was performed using a DRG Diagnostics β-Endorphin Kit (RIA 3023). The procedure was described in detail in our previous study. 21 
| Olfactory identification and hedonic assessment
The University of Pennsylvania Smell Identification Test (UPSIT)
is a well-established, standardized tool consisting of a fourchoice test with 40 items. The UPSIT was performed birhinally.
Participants scratched each microcapsuled odor patch with a pencil, sniffed it, and then indicated the name of the odor from among 4 responses. The UPSIT items were divided into pleasant, neutral, and unpleasant category using published pleasantness ratings from UPSIT manual. 23, 24 In total, 16 items (UPSIT P) were categorized as pleasant (bubble gum, cherry, banana, fruit punch, licorice, cinnamon, strawberry, chocolate, root beer, pineapple, lime, orange, wintergreen, watermelon, grape, and melon), 15 items (UPSIT N)
were categorized as neutral (menthol, mint, clove, coconut, cheddar cheese, cedar, ginger bread, lilac, peach, dill pickle, grass, pine, soap, rose, and peanut), and 9 items (UPSIT U) were categorized as unpleasant (pizza, motor oil, leather, onion, gasoline, turpentine, paint thinner, smoke, and natural gas). Additionally, all subjects rated each UPSIT odor subjectively as pleasant (+1 point), neutral (0 points), or unpleasant (−1 point). To assess participants' subjective odor hedonic value, mean hedonic rating for each category (rated from −1 to +1) was analyzed.
| Statistical analysis
To describe the study group structure, indexes were calculated for qualitative characteristics, while arithmetic mean and median (Me)
were calculated for quantitative traits. As a measure of the dispersion, standard deviation (SD) was adopted. In addition, the range of the tested variables, that is, minimum and maximum values, the confidence interval for the mean, and the asymmetry coefficient were specified. Statistical analysis of the studied characteristics (variables) was performed based on both parametric and nonparametric tests.
The empirical distributions of the studied parameters were analyzed based on the Shapiro-Wilk test. The use of parametric tests requires the assumptions of normality (eg, t test).
For measurable characteristics, the parametric t test was applied when the studied characteristics were normally distributed and a corresponding nonparametric test (equivalent of the t test), in this case, the Mann-Whitney U test, when the distribution of the studied traits was not normal. As the use of the parametric test was also dependent on the homogeneity of variance, Levene's test was applied to test this assumption. The Spearman's rank correlation coefficient was used in the study due to the distribution of the studied characteristics. The differences between more than 2 groups were tested by the Kruskal-Wallis test. P-values below .05 were regarded as statistically significant. Statistical and graphical analysis was performed using Statistica software and MS Office 2007.
| RE SULTS
| β-Endorphin concentration
Significant differences in BE concentrations were observed among study groups (ANOVA F = 8.78, P = .01). Patients with predominant negative symptoms had significantly higher blood BE concentration than other patients (Mann-Whitney test Z = 2.46, P = .01) and controls (Mann-Whitney test Z = 2.60, P = .00). There was no difference in BE concentration between the PP and control groups (MannWhitney test Z = −0.47, P = .64) (Figure 1 ). No statistically significant relationship was found between BE concentration and odor identification or odor hedonic judgment for patient samples or controls.
The sex of the subjects had no impact on BE concentrations (P = .12).
| Olfactory identification and hedonic judgment
| PN vs controls
The PN group achieved significantly lower total UPSIT (UPSIT T)
scores than controls (F = 36.00, P = .00). They demonstrated poorer BE, β-endorphin; UPSIT T, total UPSIT odors correct identification score; UPSIT P, pleasant odors correct identification score; UPSIT N, neutral odors correct identification score; UPSIT U, unpleasant odors correct identification score; HT, hedonic judgment of all UPSIT odors; H P, hedonic judgment of pleasant odors; H N, hedonic judgment of neutral odors; H U, hedonic judgment of unpleasant odors; PANSS, Positive and Negative Syndrome Scale.
TA B L E 1 Sample characteristics for schizophrenia with predominant negative symptoms (PN), schizophrenia (PP), and control groups identification of all UPSIT items: pleasant (UPSIT P: F = 30.03, P = .00), neutral (UPSIT N: F = 25.06, P = .00), and unpleasant (UPSIT U: F = 0.008, P = .00). Although little difference was seen between the PN group and controls with regard to total UPSIT hedonic item evaluation (F = 4.83, P = .09, mean H T = 0.43 vs 0.28, P = .05), the PN group rated pleasant and unpleasant odors as more pleasant (F = 7.12, P = .03; mean H P = 0.68 vs 0.51, P = .01 and F = 6.01, P = .05; mean H U = −0.09 vs −0.36, P = .04). There was no difference in neutral odors judgment.
| PP vs controls
Patients made significantly more identification errors in UPSIT (F = 36.00, P = .00) than controls (UPSIT T: Mann-Whitney test Z = −3.364, P = .00), particularly in pleasant odor identification
(UPSIT P: Mann-Whitney test Z = −4.24, P = .00). No differences in
UPSIT score for neutral and unpleasant odors were found. Patients without predominant negative symptoms judged all UPSIT items hedonic similar to controls. Among both patient samples, we found no statistically significant relationship between psychopathological symptoms severity and olfactory identification and hedonic judgment. There was no difference among study groups in terms of sex in UPSIT and hedonic performance.
| PN vs PP
| CON CLUS ION
Both patient samples made more identification errors in UPSIT than controls, which replicated most of the findings of previously published reports. 5, 9, 25 Several researchers have reported an association between odor identification deficits in UPSIT and negative symptoms. 9, [26] [27] [28] The PN group was also found to achieve the lowest F I G U R E 1 Blood concentration of β-endorphin in study samples. PN, patients with predominant negative symptoms; PP, patients without predominant negative symptoms and controls F I G U R E 2 Odor identification accuracy in study samples (percent of correctly identified UPSIT odors). PN, patients with predominant negative symptoms; PP, patients without predominant negative symptoms and controls; UPSIT T, total score; UPSIT P, pleasant odors score; UPSIT N, neutral odors score; UPSIT U, unpleasant odors score
Odor hedonic judgment in study samples. PN, patients with predominant negative symptoms; PP, patients without predominant negative symptoms and controls; H T, total UPSIT odors hedonic judgment; HP, pleasant odors hedonic judgment; H N, neutral odors hedonic judgment; HU, unpleasant odors hedonic judgment UPSIT score among the study groups, which suggests that the nega- It might be hypothesized that individuals with schizophrenia have a bias for preferential processing of negative stimuli. 29 However, in our study, the PN group judged both pleasant and unpleasant odors to be more pleasant than controls, and unpleasant odors to be more pleasant than the PP group. In general, PP and controls evaluated odor hedonic without significant differences. Similar to our findings, Cumming et al 2 reported that patients with schizophrenia rated odors as more pleasant than did the healthy volunteers. Particularly correctly identified items were rated as more pleasant, and patients who have more negative symptoms tend to have a more restricted hedonic preference range. Our observations in this issue are also coherent with those described by Doop and Park. 30 They found that patients with negative symptoms, particularly with flat affect, tend to judge odors as more pleasant, and the schizophrenics gave more positive pleasantness ratings overall. These observations suggest that schizophrenia might impair experiencing unpleasantness, and this phenomenon is exacerbated by severe negative symptoms.
Nevertheless, not only the type but also the severity of the psychopathological symptoms may play a significant role in the identification and hedonic judgment of odors. Strauss et al 25 report that patients with deficit schizophrenia identified both pleasant and unpleasant odorants with less accuracy relative to nondeficit patients and controls. On the contrary, the deficit schizophrenia patients tested in the pleasant study rated pleasant items as being less pleasant than controls and nondeficit patients, while nondeficit patients and controls did not differ in pleasantness ratings. However, both patient samples rating unpleasant items as being less unpleasant than controls. Despite some dissimilarity, both ours and other studies indicate a reduced responsiveness to positively valenced stimuli in schizophrenia.
Anhedonia is an enduring and treatment-resistant negative symptom in the presentation of schizophrenia. 31 According to the anhedonia hypothesis, dopamine is thought to be a "pleasure neurotransmitter." Presumably, the neuroleptics' induced suppression of dopamine neurotransmission results reduced hedonic impact for rewards and thus anhedonia. Nevertheless, it has been suggested that dopamine does not mediate human subjective ratings for the pleasantness of food or drug rewards. 36 The dopamine serves as a signal coding for a deviation or error between the actual reward received and the one expected. 19 Some evidence
indicates that individuals with schizophrenia experience deficits in pleasure related to future activities (anticipatory pleasure), but not in pleasure experienced in the moment (consummatory pleasure). may be a useful construct for explaining abnormal hedonic experiences in most patients. 39 We found increased concentrations of BE in schizophrenic patients with predominant negative symptoms relative to other participants. Surprisingly, there was no correlation between BE concentration, olfactory identification accuracy, and hedonic judgment.
It seems that BE is not involved, at least directly, in olfactory performance in schizophrenia. It might assume that patients with schizophrenia exhibit specific pattern of BE concentration relative to the predominant psychopathology. Nevertheless, further research on larger and more homogenous samples is needed to better understand this interesting phenomenon.
One of several limitations of the present study is lack of cigarette smoking data in both study groups. However, the majority of studies did not find a significant impact of this factor on olfactory performance in schizophrenia. 6 The significance of correlations in our results should be interpreted with caution due to relatively small samples size. There were no individuals with deficit syndrome or great severity of negative symptoms in our patients' sample. It should be assumed that the correlations in case of severe negative symptoms might be significant. The olfactory performance investigation in our study did not include any odor intensity assessment.
Some recent research indicates that odor concentration might determinate its hedonic judgment in patients with schizophrenia. 32 The majority of studies referring to olfactory performance in schizophrenia evaluated outpatient samples.
Both our patient samples were drawn from an inpatient unit, which could be considered both a limitation and an advantage of this study.
The inpatient population is typically affected by various psychopathological symptoms, including severe cognitive disorders which were not assessed in the study. These additional symptoms may also influence olfactory performance and make patient samples less homogeneous.
Another limitation was that no direct analysis was made of the relationship between pharmacological treatment and measured variables.
Although it is thought that antipsychotic treatment has no impact on olfactory performance in schizophrenia, 6 it could affect BE concentration. It should be noted that we measured BE concentration in blood samples. Thus, our BE concentration results might not directly reflect brain BE levels.
Schizophrenic patients with predominant negative symptoms demonstrate significant deficits in olfactory identification, especially in pleasant odors, which might also indicate a reduced responsiveness to positive/pleasant stimuli. Nevertheless, they tend to judge odor subjectively as more pleasant. These findings indicate that deficits in odor identification might be differentially expressed in some subtypes of schizophrenia. Valence judgment could be impaired, or even selective, to patients with predominantly negative symptoms. However, it should be noted that PN sample in our study had not only severe negative symptoms but also other psychopathological symptoms of schizophrenia. Thus, both of these factors might have impact on patients' olfactory performance. Further research investigating pleasant odors identification deficits might assess this feature as a potential risk factor for persistent negative symptoms. BE is related to a predominant negative symptomatology of schizophrenia, but presumably, it is not directly involved in the olfactory performance deficits observed in this psychosis.
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